Lourdes Felix
Vorstandsvorsitzender bei BIOCORRX INC.
Vermögen: 117 791 $ am 30.04.2024
Aktive Positionen von Lourdes Felix
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCORRX INC. | Direktor/Vorstandsmitglied | 07.03.2013 | - |
Vorstandsvorsitzender | 09.11.2020 | - | |
Geschäftsführer | - | - | |
Finanzdirektor/CFO | 01.10.2012 | - | |
Comptroller/Controller/Auditor | - | 02.03.2020 | |
Präsident | 26.02.2020 | 09.11.2020 | |
Treasurer | 01.10.2012 | 17.06.2016 | |
SIYATA MOBILE INC. | Direktor/Vorstandsmitglied | 29.10.2021 | - |
Independent Dir/Board Member | 29.10.2021 | - | |
LICHEN CHINA LIMITED | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
AVALON GLOBOCARE CORP. | Direktor/Vorstandsmitglied | 09.01.2023 | - |
Independent Dir/Board Member | 09.01.2023 | - | |
LA ROSA HOLDINGS CORP. | Direktor/Vorstandsmitglied | 19.04.2024 | - |
Independent Dir/Board Member | 19.04.2024 | - | |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Direktor/Vorstandsmitglied | - | - |
Geschäftsführer | - | - | |
Finanzdirektor/CFO | - | - | |
Gründer | - | - | |
Präsident | - | - | |
Vocodia Holdings Corp.
Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Direktor/Vorstandsmitglied | 22.02.2024 | - |
Independent Dir/Board Member | 22.02.2024 | - |
Karriereverlauf von Lourdes Felix
Ausbildung von Lourdes Felix
University of Phoenix | Undergraduate Degree |
D'Amore-Mckim School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Kanada | 2 |
China | 2 |
Operativ
Director/Board Member | 7 |
Independent Dir/Board Member | 5 |
Chief Operating Officer | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
BIOCORRX INC. | Health Services |
AVALON GLOBOCARE CORP. | Health Technology |
SIYATA MOBILE INC. | Electronic Technology |
LICHEN CHINA LIMITED | Commercial Services |
Technology Services | |
LA ROSA HOLDINGS CORP. | Finance |
Private Unternehmen | 1 |
---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
- Börse
- Insiders
- Lourdes Felix
- Erfahrung